These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21496246)

  • 1. Supramolecular assemblies of rifampicin and cationic bilayers: preparation, characterization and micobactericidal activity.
    Barbassa L; Mamizuka EM; Carmona-Ribeiro AM
    BMC Biotechnol; 2011 Apr; 11():40. PubMed ID: 21496246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial particles from cationic lipid and polyelectrolytes.
    Melo LD; Mamizuka EM; Carmona-Ribeiro AM
    Langmuir; 2010 Jul; 26(14):12300-6. PubMed ID: 20578678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonquaternary poly(diallylammonium) polymers with different amine structure and their biocidal effect on Mycobacterium tuberculosis and Mycobacterium smegmatis.
    Timofeeva LM; Kleshcheva NA; Shleeva MO; Filatova MP; Simonova YA; Ermakov YA; Kaprelyants AS
    Appl Microbiol Biotechnol; 2015 Mar; 99(6):2557-71. PubMed ID: 25557627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable assemblies of cationic bilayer fragments and CpG oligonucleotide with enhanced immunoadjuvant activity in vivo.
    Rozenfeld JH; Silva SR; Ranéia PA; Faquim-Mauro E; Carmona-Ribeiro AM
    J Control Release; 2012 Jun; 160(2):367-73. PubMed ID: 22036878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-covered drug particles: combined action of dioctadecyldimethylammonium bromide and amphotericin B or miconazole.
    Lincopan N; Carmona-Ribeiro AM
    J Antimicrob Chemother; 2006 Jul; 58(1):66-75. PubMed ID: 16636081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel gramicidin formulations in cationic lipid as broad-spectrum microbicidal agents.
    Ragioto DA; Carrasco LD; Carmona-Ribeiro AM
    Int J Nanomedicine; 2014; 9():3183-92. PubMed ID: 25061295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silica-based cationic bilayers as immunoadjuvants.
    Lincopan N; Santana MR; Faquim-Mauro E; da Costa MH; Carmona-Ribeiro AM
    BMC Biotechnol; 2009 Jan; 9():5. PubMed ID: 19152701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of DODAB/DPPC vesicles.
    Sobral CN; Soto MA; Carmona-Ribeiro AM
    Chem Phys Lipids; 2008 Mar; 152(1):38-45. PubMed ID: 18258186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive phenotypic characterization of rifampicin resistance mutations in Salmonella provides insight into the evolution of resistance in Mycobacterium tuberculosis.
    Brandis G; Pietsch F; Alemayehu R; Hughes D
    J Antimicrob Chemother; 2015 Mar; 70(3):680-5. PubMed ID: 25362573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis.
    Maltempe FG; Caleffi-Ferracioli KR; do Amaral RCR; de Oliveira Demitto F; Siqueira VLD; de Lima Scodro RB; Hirata MH; Pavan FR; Cardoso RF
    Tuberculosis (Edinb); 2017 May; 104():24-29. PubMed ID: 28454646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel immunoadjuvants based on cationic lipid: Preparation, characterization and activity in vivo.
    Lincopan N; Espíndola NM; Vaz AJ; da Costa MH; Faquim-Mauro E; Carmona-Ribeiro AM
    Vaccine; 2009 Sep; 27(42):5760-71. PubMed ID: 19664738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-folates potentiate bactericidal effects of other antimicrobial agents.
    Li K; Wang XD; Yang SS; Gu J; Deng JY; Zhang XE
    J Antibiot (Tokyo); 2017 Mar; 70(3):285-291. PubMed ID: 28074051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly of a model hydrophobic drug into cationic bilayer fragments.
    Vieira DB; Pacheco LF; Carmona-Ribeiro AM
    J Colloid Interface Sci; 2006 Jan; 293(1):240-7. PubMed ID: 16095603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative Pharmaceutical Formulation for Oral Administration of Rifampicin.
    Halicki PCB; Hädrich G; Boschero R; Ferreira LA; von Groll A; da Silva PEA; Dora CL; Ramos DF
    Assay Drug Dev Technol; 2018 Dec; 16(8):456-461. PubMed ID: 30325673
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitory activity of traditional plants against Mycobacterium smegmatis and their action on Filamenting temperature sensitive mutant Z (FtsZ)-A cell division protein.
    Ravindran R; Chakrapani G; Mitra K; Doble M
    PLoS One; 2020; 15(5):e0232482. PubMed ID: 32357366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of cationic vesicle with ribonucleotides (AMP, ADP, and ATP) and physicochemical characterization of DODAB/ribonucleotides complexes.
    Liu S; Lu G
    Biophys Chem; 2007 Apr; 127(1-2):19-27. PubMed ID: 17182168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
    Coban AY; Bilgin K; Uzun M; Durupinar B
    Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.
    Herbert D; Paramasivan CN; Venkatesan P; Kubendiran G; Prabhakar R; Mitchison DA
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2296-9. PubMed ID: 8891133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of gramicidin with DPPC/DODAB bilayer fragments.
    Carvalho CA; Olivares-Ortega C; Soto-Arriaza MA; Carmona-Ribeiro AM
    Biochim Biophys Acta; 2012 Dec; 1818(12):3064-71. PubMed ID: 22960286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.